SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2.
作者信息
Allison Susan J
机构信息
Nature Reviews Nephrology, .
出版信息
Nat Rev Nephrol. 2020 Jun;16(6):316. doi: 10.1038/s41581-020-0291-8.
Abstract
摘要
相似文献
1
SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2.
Nat Rev Nephrol. 2020 Jun;16(6):316. doi: 10.1038/s41581-020-0291-8.
2
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Eur J Intern Med. 2020 Jun;76:14-20. doi: 10.1016/j.ejim.2020.04.037. Epub 2020 Apr 20.
3
Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
mBio. 2020 Dec 11;11(6):e03185-20. doi: 10.1128/mBio.03185-20.
4
ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
Lung. 2020 Dec;198(6):867-877. doi: 10.1007/s00408-020-00408-4. Epub 2020 Nov 10.
5
Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.
Clin Sci (Lond). 2020 May 29;134(10):1143-1150. doi: 10.1042/CS20200419.
6
Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.
Front Mol Biosci. 2020 Oct 16;7:568954. doi: 10.3389/fmolb.2020.568954. eCollection 2020.
7
Single-cell expression profiles of and reveals potential vertical transmission and fetus infection of SARS-CoV-2.
Aging (Albany NY). 2020 Oct 26;12(20):19880-19897. doi: 10.18632/aging.104015.
8
Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.
Eye (Lond). 2020 Jul;34(7):1212-1219. doi: 10.1038/s41433-020-0939-4. Epub 2020 May 7.
9
Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
Mol Genet Genomic Med. 2020 Oct;8(10):e1442. doi: 10.1002/mgg3.1442. Epub 2020 Aug 3.
10
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Cardiovasc Res. 2020 Aug 1;116(10):1733-1741. doi: 10.1093/cvr/cvaa191.
引用本文的文献
1
Mapping the scientific output of organoids for animal and human modeling infectious diseases: a bibliometric assessment.
Vet Res. 2024 Jun 26;55(1):81. doi: 10.1186/s13567-024-01333-7.
2
Insights into organoid-based modeling of COVID-19 pathology.
Virol J. 2023 Feb 25;20(1):37. doi: 10.1186/s12985-023-01996-2.
3
Cell and Animal Models for SARS-CoV-2 Research.
Viruses. 2022 Jul 9;14(7):1507. doi: 10.3390/v14071507.
4
Potential Similarities in Sex Difference in Key Genes and Their Expression, Network, EQTL and Pathways between COVID-19 and Chronic Kidney Disease Based on Mouse Model.
J Pers Med. 2022 Jul 21;12(7):1190. doi: 10.3390/jpm12071190.
5
Kidney organoids as a promising tool in nephrology.
Genes Dis. 2021 Jan 30;9(3):585-597. doi: 10.1016/j.gendis.2021.01.003. eCollection 2022 May.
6
Retina stem cells, hopes and obstacles.
World J Stem Cells. 2021 Oct 26;13(10):1446-1479. doi: 10.4252/wjsc.v13.i10.1446.
7
An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models.
J Mol Biol. 2022 Feb 15;434(3):167213. doi: 10.1016/j.jmb.2021.167213. Epub 2021 Aug 23.
8
Advances in development and application of human organoids.
3 Biotech. 2021 Jun;11(6):257. doi: 10.1007/s13205-021-02815-7. Epub 2021 May 8.
9
Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19.
Life Sci. 2021 Aug 1;278:119510. doi: 10.1016/j.lfs.2021.119510. Epub 2021 Apr 15.
10
COVID-19 effects on the kidney.
Pathologe. 2021 Nov;42(Suppl 1):76-80. doi: 10.1007/s00292-020-00900-x. Epub 2021 Mar 1.
本文引用的文献
1
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
Zotero 插件